User profiles for Michail N. Mavros

Michail N. Mavros, MD

Assistant Professor, University of Arkansas for Medical Sciences
Verified email at uams.edu
Cited by 4136

Clinical trials of systemic chemotherapy for resectable pancreatic cancer: a review

MN Mavros, D Moris, PJ Karanicolas, MHG Katz… - JAMA …, 2021 - jamanetwork.com
Importance Adjuvant chemotherapy is the standard of care for resected pancreatic ductal
adenocarcinoma (PDAC) based on level 1 evidence, but some studies suggest that a …

[HTML][HTML] Adjuvant transarterial chemoembolization following curative-intent hepatectomy versus hepatectomy alone for hepatocellular carcinoma: a systematic review …

…, E Giorgakis, L Burdine, JC Barreto, MN Mavros - Cancers, 2021 - mdpi.com
Simple Summary The role of postoperative transarterial chemoembolization (TACE) after
liver resection for hepatocellular carcinoma (HCC) remains unclear. We performed a …

Population-level symptom assessment following pancreaticoduodenectomy for adenocarcinoma

S Tung, LE Davis, J Hallet, MN Mavros, AL Mahar… - JAMA …, 2019 - jamanetwork.com
Importance Postoperative morbidity associated with pancreaticoduodenectomy (PD) for
pancreatic adenocarcinoma (PA) remains as high as 70%. However, to our knowledge, few …

Low rates of specialized cancer consultation and cancer-directed therapy for noncurable pancreatic adenocarcinoma: a population-based analysis

MN Mavros, NG Coburn, LE Davis, AL Mahar, Y Liu… - Cmaj, 2019 - Can Med Assoc
BACKGROUND: Although advancements in systemic therapy have improved the outlook for
pancreatic adenocarcinoma, it is not known if patients get access to these therapies. We …

Artificial intelligence in liver transplantation

…, CD Kakos, I Anastasiou, MN Mavros… - Transplantation …, 2021 - Elsevier
Background Advancements based on artificial intelligence have emerged in all areas of
medicine. Many decisions in organ transplantation can now potentially be addressed in a more …

Predictors of sentinel lymph node metastasis in patients with thin melanoma: an international multi-institutional collaboration

…, JG McKinnon, FC Wright, MN Mavros - Annals of Surgical …, 2022 - Springer
… Patients with clinical or radiologic evidence of advanced disease at diagnosis (N+ or M+,
including … Gregory McKinnon, and Michail N. Mavros have no conflicts of interest to declare. …

Symptom burden of nonresected pancreatic adenocarcinoma: an analysis of 10,753 patient-reported outcome assessments

MN Mavros, LE Davis, J Hallet, S Tung, AL Mahar… - Pancreas, 2020 - journals.lww.com
Objectives Pancreatic adenocarcinoma (PAC) is a debilitating disease. We sought to analyze
symptom burden and trajectories after diagnosis of PAC and identify predictors of severe …

Complications and failure-to-rescue after pancreatectomy and hospital participation in the targeted American College of Surgeons National Surgical Quality …

…, S Kuhn, H Pitt, A Wells, HK Jensen, MN Mavros - Surgery, 2023 - Elsevier
Background More than 700 hospitals participate in the American College of Surgeons National
Surgical Quality Improvement Program, but most pancreatectomies are performed in 165 …

Fluoroquinolone-based versus β-lactam-based regimens for complicated intra-abdominal infections: a meta-analysis of randomised controlled trials

MN Mavros, NA Theochari, M Kyriakidou… - International journal of …, 2019 - Elsevier
Complicated intra-abdominal infections (cIAIs) are common and confer significant morbidity,
mortality and costs. In this era of evolving antimicrobial resistance, selection of appropriate …

Morbidity of colectomy during pancreatoduodenectomy: An analysis of the pancreas‐targeted American College of Surgeons National Surgical Quality Improvement …

…, HK Jensen, E Giorgakis, MN Mavros - Journal of Hepato …, 2023 - Wiley Online Library
Background Pancreatoduodenectomy is a complex operation with considerable morbidity
and mortality. Locally advanced tumors may require concurrent colectomy. We hypothesized …